| Naraparaju, Koumudi; Kolla, Venkatadri; Zhuang, Tiangang et al. (2016) Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas. Oncotarget 7:15977-85 |
| Thompson, Daria; Vo, Kieuhoa T; London, Wendy B et al. (2016) Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer 122:935-45 |
| Higashi, Mayumi; Kolla, Venkatadri; Iyer, Radhika et al. (2015) Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma. Mol Cancer 14:150 |
| Kolla, Venkatadri; Naraparaju, Koumudi; Zhuang, Tiangang et al. (2015) The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex. Biochem J 468:345-52 |
| Brodeur, Garrett M; Iyer, Radhika; Croucher, Jamie L et al. (2014) Therapeutic targets for neuroblastomas. Expert Opin Ther Targets 18:277-92 |
| Brodeur, Garrett M; Bagatell, Rochelle (2014) Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol 11:704-13 |
| Zhuang, Tiangang; Hess, Rex A; Kolla, Venkatadri et al. (2014) CHD5 is required for spermiogenesis and chromatin condensation. Mech Dev 131:35-46 |
| Kolla, Venkatadri; Zhuang, Tiangang; Higashi, Mayumi et al. (2014) Role of CHD5 in human cancers: 10 years later. Cancer Res 74:652-8 |
| Garcia, Idoia; Mayol, Gemma; Rios, Jose et al. (2012) A three-gene expression signature model for risk stratification of patients with neuroblastoma. Clin Cancer Res 18:2012-23 |
| Schleiermacher, G; Mosseri, V; London, W B et al. (2012) Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br J Cancer 107:1418-22 |
Showing the most recent 10 out of 102 publications
